Corcept Therapeutics Incorporated
IT ˙ BIT ˙ US2183521028
62,12 € ↑0,86 (1,40%)
2026-06-03
AKTIENPREIS
SecurityIT:1CORT / Corcept Therapeutics Incorporated
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership1,181,348 shares
Latest Disclosed Value $ 47,620,138
D. E. Shaw & Co., Inc. ownership in 1CORT / Corcept Therapeutics Incorporated

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 1,181,348 shares of Corcept Therapeutics Incorporated (IT:1CORT) valued at $39,976,816 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 169,667 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 596.27% during the quarter. The current value of the position is $73,385,338 USD.

D. E. Shaw & Co., Inc. has a history of taking positions in derivatives of the underlying security (1CORT) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1CORT / Corcept Therapeutics Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,181,348 1,011,681 596.27 47,620 706.57 0.0286
2026-02-17 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 169,667 -414,431 -70.95 5,904 -87.84 0.0032
2025-11-14 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 584,098 -89,039 -13.23 48,544 -1.75 0.0274
2025-08-14 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 673,137 -27,127 -3.87 49,408 -38.23 0.0350
2025-05-15 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 700,264 -186,312 -21.01 79,984 79.04 0.0712
2025-02-14 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 886,576 98,512 12.50 44,675 22.49 0.0328
2024-11-14 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 788,064 -161,079 -16.97 36,472 18.27 0.0313
2024-08-14 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 949,143 -183,941 -16.23 30,838 8.04 0.0288
2024-05-15 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,133,084 -525,554 -31.69 28,542 -47.02 0.0244
2024-02-14 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,658,638 140,531 9.26 53,873 30.25 0.0471
2023-11-14 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 1,518,107 368,458 32.05 41,361 61.70 0.0432
2023-08-14 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 1,149,649 365,450 46.60 25,580 50.60 0.0261
2023-05-15 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 784,199 -408,159 -34.23 16,986 -29.86 0.0182
2023-02-14 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 1,192,358 -419,466 -26.02 24,217 -41.40 0.0268
2022-11-14 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 1,611,824 404 0.03 41,327 7.85 0.0494
2022-08-15 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 1,611,420 492,709 44.04 38,319 52.10 0.0449
2022-05-16 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 1,118,711 724,963 184.12 25,194 223.17 0.0236
2022-02-14 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 393,748 168,071 74.47 7,796 75.55 0.0065
2021-11-15 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 225,677 88,821 64.90 4,441 47.49 0.0040
2021-08-16 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 136,856 -148,261 -52.00 3,011 -55.61 0.0026
2021-05-17 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 285,117 -256,642 -47.37 6,783 -52.14 0.0065
2021-02-16 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 541,759 116,192 27.30 14,172 91.33 0.0127
2020-11-16 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 425,567 100,813 31.04 7,407 35.61 0.0076
2020-08-14 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 324,754 40,517 14.25 5,462 61.60 0.0065
2020-05-15 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 284,237 19,617 7.41 3,380 5.56 0.0053
2020-02-14 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 264,620 -112,113 -29.76 3,202 -39.87 0.0037
2019-11-14 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 376,733 203,976 118.07 5,325 176.34 0.0066
2019-08-14 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 172,757 160,485 1,307.73 1,927 1,238.19 0.0024
2019-05-15 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 12,272 -518,511 -97.69 144 -97.97 0.0002
2019-02-14 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 530,783 401,493 310.54 7,091 291.12 0.0098
2018-11-14 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 129,290 129,290 1,813 0.0022
2018-08-14 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 0 -58,928 -100.00 0 -100.00
2018-05-15 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 58,928 -62,997 -51.67 969 -55.99 0.0013
2018-02-14 2017-12-31 13F CORCEPT THERAPEUTICS COM 218352102 121,925 -218,193 -64.15 2,202 -66.45 0.0030
2017-11-14 2017-09-30 13F CORCEPT THERAPEUTICS COM 218352102 340,118 50,585 17.47 6,564 92.15 0.0101
2017-08-14 2017-06-30 13F CORCEPT THERAPEUTICS COM 218352102 289,533 61,508 26.97 3,416 36.69 0.0057
2017-05-15 2017-03-31 13F CORCEPT THERAPEUTICS COM 218352102 228,025 -203,861 -47.20 2,499 -20.31 0.0044
2017-02-14 2016-12-31 13F CORCEPT THERAPEUTICS COM 218352102 431,886 290,102 204.61 3,136 240.50 0.0053
2016-11-14 2016-09-30 13F CORCEPT THERAPEUTICS COM 218352102 141,784 33,351 30.76 921 55.57 0.0016
2016-08-15 2016-06-30 13F CORCEPT THERAPEUTICS COM 218352102 108,433 32,922 43.60 592 67.71 0.0011
2016-05-16 2016-03-31 13F CORCEPT THERAPEUTICS COM 218352102 75,511 -165,198 -68.63 353 -70.56 0.0006
2016-02-16 2015-12-31 13F CORCEPT THERAPEUTICS COM 218352102 240,709 153,588 176.29 1,199 266.67 0.0018
2015-11-16 2015-09-30 13F CORCEPT THERAPEUTICS COM 218352102 87,121 72,783 507.62 327 610.87 0.0005
2014-02-14 2013-12-31 13F CORCEPT THERAPEUTICS COM 218352102 14,338 1,005 7.54 46 119.05 0.0001
2013-11-20 2013-09-30 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 13,333 -2,000 -13.04 21 -22.22 0.0000
2013-11-14 2013-09-30 13F CORCEPT THERAPEUTICS COM 218352102 13,333 21
2013-08-14 2013-06-30 13F CORCEPT THERAPEUTICS COM 218352102 15,333 15,333 27 0.0001
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F CORCEPT THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F CORCEPT THERAPEUTICS COM Put 45,000 3,740 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.